Aviance Capital Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.22M Buy
33,621
+842
+3% +$196K 0.96% 20
2025
Q4
$6.78M Sell
32,779
-261
-0.8% -$51.6K 0.78% 25
2025
Q3
$6.13M Sell
33,040
-7,010
-18% -$1.2M 0.73% 26
2025
Q2
$6.12M Buy
40,050
+430
+1% +$66.1K 0.8% 25
2025
Q1
$6.57M Sell
39,620
-887
-2% -$139K 0.92% 23
2024
Q4
$5.86M Buy
40,507
+1,972
+5% +$306K 0.81% 25
2024
Q3
$6.24M Sell
38,535
-665
-2% -$106K 0.82% 26
2024
Q2
$5.73M Buy
39,200
+1,382
+4% +$206K 0.82% 27
2024
Q1
$5.98M Buy
37,818
+14,663
+63% +$2.33M 0.89% 24
2023
Q4
$3.63M Sell
23,155
-534
-2% -$81.9K 0.78% 34
2023
Q3
$3.69M Sell
23,689
-1,043
-4% -$172K 0.83% 36
2023
Q2
$4.09M Buy
24,732
+339
+1% +$54.7K 0.87% 32
2023
Q1
$3.78M Buy
24,393
+642
+3% +$104K 0.84% 32
2022
Q4
$4.2M Buy
23,751
+351
+2% +$60.6K 0.98% 27
2022
Q3
$3.82M Sell
23,400
-1,024
-4% -$173K 0.95% 25
2022
Q2
$4.34M Buy
24,424
+1,022
+4% +$182K 0.97% 25
2022
Q1
$4.15M Buy
23,402
+34
+0.1% +$5.79K 0.76% 32
2021
Q4
$4M Sell
23,368
-200
-0.8% -$32.7K 0.67% 41
2021
Q3
$3.81M Sell
23,568
-231
-1% -$39.4K 0.67% 38
2021
Q2
$3.92M Buy
23,799
+24
+0.1% +$3.97K 0.69% 36
2021
Q1
$3.91M Buy
23,775
+475
+2% +$76.9K 0.75% 36
2020
Q4
$3.67M Sell
23,300
-10
-0% -$1.48K 0.74% 33
2020
Q3
$3.47M Buy
23,310
+360
+2% +$53.3K 0.78% 30
2020
Q2
$3.23M Sell
22,950
-11
-0% -$1.6K 0.8% 29
2020
Q1
$3.01M Sell
22,961
-721
-3% -$102K 0.95% 20
2019
Q4
$3.46M Buy
23,682
+844
+4% +$114K 0.88% 19
2019
Q3
$2.96M Sell
22,838
-903
-4% -$119K 0.87% 21
2019
Q2
$3.31M Sell
23,741
-114
-0.5% -$15.8K 0.91% 14
2019
Q1
$3.33M Buy
23,855
+85
+0.4% +$11.4K 0.96% 15
2018
Q4
$3.07M Buy
23,770
+409
+2% +$57.1K 1.08% 15
2018
Q3
$3.23M Buy
23,361
+264
+1% +$35.1K 0.78% 18
2018
Q2
$2.8M Buy
23,097
+419
+2% +$52.3K 0.81% 21
2018
Q1
$2.91M Sell
22,678
-10
-0% -$1.35K 0.88% 22
2017
Q4
$3.17M Buy
22,688
+482
+2% +$67.1K 1.05% 13
2017
Q3
$2.89M Buy
22,206
+5
+0% +$663 0.98% 17
2017
Q2
$2.94M Buy
22,201
+1,442
+7% +$184K 0.95% 19
2017
Q1
$2.59M Buy
20,759
+162
+0.8% +$19.4K 0.94% 23
2016
Q4
$2.37M Buy
20,597
+243
+1% +$28.1K 0.84% 26
2016
Q3
$2.4M Sell
20,354
-388
-2% -$47.1K 0.85% 30
2016
Q2
$2.52M Sell
20,742
-5,884
-22% -$669K 0.93% 26
2016
Q1
$2.88M Buy
26,626
+1,063
+4% +$110K 1% 18
2015
Q4
$2.63M Sell
25,563
-1,258
-5% -$127K 0.9% 22
2015
Q3
$2.5M Buy
26,821
+220
+0.8% +$21.3K 1.03% 19
2015
Q2
$2.59M Sell
26,601
-63
-0.2% -$6.31K 0.97% 19
2015
Q1
$2.68M Sell
26,664
-160
-0.6% -$16.3K 0.98% 19
2014
Q4
$2.81M Buy
26,824
+125
+0.5% +$13.2K 1.05% 14
2014
Q3
$2.85M Buy
26,699
+439
+2% +$45.5K 1.08% 13
2014
Q2
$2.75M Sell
26,260
-265
-1% -$26.8K 1.07% 13
2014
Q1
$2.61M Sell
26,525
-99
-0.4% -$9.18K 1.1% 15
2013
Q4
$2.44M Sell
26,624
-1,613
-6% -$149K 1.03% 20
2013
Q3
$2.45M Buy
28,237
+10,396
+58% +$933K 1.14% 18
2013
Q2
$1.53M Buy
+17,841
New +$1.51M 0.83% 31

Other funds holding JNJ

Aviance Capital Partners's JNJ Position: Q1 2026 in Review

Aviance Capital Partners increased its Johnson & Johnson (JNJ) stake by 2.6% in Q1 2026, buying an estimated $196K and bringing the position to 33,621 shares worth $8.22M. The position accounts for 0.96% of the portfolio, ranked #20.

Aviance Capital Partners first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Aviance Capital Partners held 33,621 shares of Johnson & Johnson worth $8.22M as of Q1 2026.
  • Aviance Capital Partners bought 842 Johnson & Johnson shares in Q1 2026, an estimated $196K.
  • Johnson & Johnson made up 0.96% of Aviance Capital Partners's portfolio in Q1 2026, its #20 holding.
  • Aviance Capital Partners first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Aviance Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.